Latest News about Partner Content
Recent news which mentions Partner Content
H.C. Wainwright Reiterated Its Buy Rating On Bitdeer Technologies (NASDAQ: BTDR) This Month Citing A "Compelling Buying Opportunity" – Here's Why
December 11, 2023
Tickers
BTDR
From Benzinga
Tackling Aviation's Earthbound Inefficiencies
December 11, 2023
From Benzinga
InMed's (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer's With A Rare Cannabinoid Analog
December 11, 2023
Tickers
INM
From Benzinga
From Staking Land For Tuition To Being One Of Few Royalty Companies Traded For 20+ Years – A Brief History Of Altius Minerals
December 11, 2023
From Benzinga
Givex (OTCQX: GIVXF) Reports Q3 2023 Financial Results: Revenues Up, Net Loss Narrowed By 71%
December 11, 2023
Tickers
GIVXF
From Benzinga
Global Population Projected To Cross 9 Billion By 2050, Food Security A Concern – Why Steakholder Foods' (NASDAQ: STKH) 3D Printed Meat Could Help
December 11, 2023
Tickers
STKH
From Benzinga
Grid Battery Metals Tackles The Looming Lithium Crisis Amid Electric Vehicle Revolution
December 07, 2023
Tickers
EVKRF
From Benzinga
ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14
December 06, 2023
Tickers
IPA
From Benzinga
How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure
December 05, 2023
Tickers
CNSP
From Benzinga
Amesite's Investments In Infrastructure Enable A No-Setup Fee Deal For Its Customers, Enabling Risk-Free Scale And Simplified Sales
December 05, 2023
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™
December 05, 2023
Tickers
LGVN
From Benzinga
From Benzinga
Iteris Inc (NASDAQ: ITI): In A Pole Position To Modernize Transportation Infrastructure In The U.S.?
December 05, 2023
Tickers
ITI
From Benzinga
"AI That Makes Everything Beautiful": Exploring Perfect Corp.'s Suite Of Cutting-Edge Apps Powered By Generative AI
December 04, 2023
Tickers
PERF
From Benzinga
How Givex's Omnichannel Solutions Can Empower Companies Across Multiple Industries
December 04, 2023
Tickers
GIVXF
From Benzinga
Amid Recent News About Lithium-Ion Battery Fires, Is There A Need For More Stringent Product Testing In The Industry? One Company May Have Answers
December 04, 2023
Tickers
DFLI
From Benzinga
Unlocking The Secrets Of Jim Cramer's Investing
December 04, 2023
From Benzinga
Ways To Diversify And Hedge Portfolios, Regardless Of Economic Climate
December 01, 2023
From Benzinga
From Benzinga
VERSES Technologies Advancing Artificial Intelligence With NASA
November 30, 2023
Tickers
VRSSF
From Benzinga
Diabetes Is The Most Expensive Chronic Condition In America With Healthcare Costs Continuing To Rise, Making Addressing Its Root Causes Even More Important
November 30, 2023
Tickers
BTTX
From Benzinga
Is This Ticker That InvestorObservers Expects To Soar By More Than 350% Next Year On Your Watchlist?
November 30, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.